Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis

The Journal of Antibiotics advance online publication, May 18 2016. doi:10.1038/ja.2016.45

Authors: Shasha Rao, Clive A Prestidge, Lynn Miesel, Deb Sweeney, Dean L Shinabarger & Ramiz A Boulos

from The Journal of Antibiotics - AOP - nature.com science feeds http://ift.tt/1XlK60I